Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,125,199
-$4,041,489 QoQ
Shares Held
475,190
-14.6% QoQ
Ownership
0.567%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Derivatives in EYPT
reported options exposure · as of Dec 31, 2025CallValue
$685,125
CallShares
37,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. EYPT ranks #157 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in EYPT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,125,199 | 475,190 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $685,125 | 37,500 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $10,166,688 | 556,469 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,878,688 | 483,054 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $358,982 | 38,149 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $166,936 | 30,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,324,182 | 446,199 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $5,052,229 | 580,716 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $42,299,873 | 2,046,438 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $924,400 | 40,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $26,082,824 | 1,128,638 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,639,225 | 580,629 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,948,838 | 338,947 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,796,863 | 611,178 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,364,015 | 675,433 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,245,362 | 410,286 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,701,165 | 343,223 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,886,469 | 155,265 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,508,004 | 123,203 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $387,655 | 37,203 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,519,012 | 502,671 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,967,288 | 292,056 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $163,078 | 24,784 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||